Читать книгу Essential Guide to Acute Care - Nicola Cooper - Страница 14

ACC/AHAAmerican College of Cardiology and American Heart AssociationACTHAdrenocorticotropic hormoneADHAnti‐diuretic hormoneAFAtrial fibrillationAKIAcute kidney injuryALIAcute lung injuryAMPAdenosine monophosphateANCAAnti‐neutrophil cytoplasmic antibodiesAPACHEAcute physiological and chronic health evaluationAQPAquaporin receptorARBsAngiotensin‐receptor blockersARDSAcute respiratory distress syndromeASAortic stenosisASAAmerican Society of AnesthesiologistsASA‐PSASA Physical StatusASBAssisted spontaneous breathsATAnaerobic thresholdATLSAdvanced Trauma and Life SupportATPAdenosine triphosphateAVPUalert, responds to voice, responds to pain, unresponsiveBEBase excessBiPAPBilevel positive airway pressureBPBlood pressureBPSBehavioural Pain ScaleBTSBritish Thoracic SocietyBUPABritish United Provident AssociationCBFCerebral blood flowCGAComprehensive geriatric assessmentCKCreatine kinaseCKDChronic kidney diseaseCOCarbon monoxideCOCardiac outputCOPDChronic obstructive pulmonary diseaseCPAPContinuous positive airway pressureCPPCerebral perfusion pressureCPRCardio‐pulmonary resuscitationCPXCardiopulmonary exerciseCRPC‐reactive proteinCTComputed tomographyCVPCentral venous pressureCVPUConfused, responds to voice, responds to pain, unresponsiveCVRCerebrovascular resistanceECGElectrocardiogramECMOExtracorporeal membrane oxygenationeGFREstimated glomerular filtration rateEPAPExpiratory pressureERASEnhanced Recovery After SurgeryERCPEndoscopic retrograde cholangio‐pancreatogramFASFunctional Activity ScoreFDAFood and Drug AdministrationFLACCFaces Legs Activity Cry ConsolabilityFVCForced vital capacityGBMGlomerular basement membraneGCSGlasgow Coma ScoreGPGeneral practitionerHASHuman albumin solutionHESHydroxyethyl starchHFmrEFHeart failure with mid‐range ejection fractionHFNOTHigh flow nasal oxygen therapyHFpEFHeart failure with a preserved ejection fractionHFrEFHeart failure with reduced ejection fractionHRHeart rateIASPInternational Association for the Study of PainICPIntracranial pressureIPAPInspiratory pressureIPPVIntermittent positive pressure ventilationIVCInferior vena cavaKDIGOKidney Disease Improving Global OutcomesLALeft atriumLEDsLight emitting diodesLPLumbar punctureLRINECLab Risk Indicator for Necrotising FasciitisLVEFLeft ventricular ejection fractionLVHLeft ventricular hypertrophyMACEMajor adverse cardiac eventsMAPMean arterial pressureMETsMedical emergency teamsMETsMetabolic equivalentsMRIMagnetic resonance imagingNCEPODNational Confidential Enquiry into Patient Outcome and DeathNEWS2National Early Warning ScoreNICENational Institute for Health and Care ExcellenceNIVNon‐invasive ventilationNSAIDsNon‐steroidal anti‐inflammatory drugsOSAObstructive sleep apnoeaPAPulmonary arteryPAMPsPathogen‐associated molecular patternsPCIPercutaneous coronary interventionPEEPPositive end‐expiratory pressurePOCUSPoint of care ultrasoundPOISEPerioperative ischaemic evaluationPOSSUMPhysiological and operative severity score for the enumeration of mortality and morbidityPSVPressure support ventilationqSOFAQuick SOFASA‐AKISepsis associated acute kidney injurySAFESaline vs. albumin evaluationSAHSubarachnoid haemorrhageSAHLSepsis‐associated hyperlactateaemiaSIMVSynchronised intermittent mandatory ventilationSIRSSystemic inflammatory response syndromeSOFASepsis‐related organ failure assessmentSORTSurgical Outcome Risk ToolSRSSurgical Risk ScaleSSCSurviving Sepsis CampaignSVStroke volumeSVRSystemic vascular resistanceTENSTranscutaneous nerve stimulationTHRIVETransnasal humidified rapid insufflation ventilatory exchangeTLRsToll‐like receptorsTTPThrombotic thrombocytopenic purpuraVANISHVasopressin versus Norepinephrine as Initial Therapy in Septic Shock TrialVASSTVasopressin and Septic Shock TrialVILIVentilator‐induced lung injury